Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-04

Clinical Trial Update: Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating whether pre-therapy imaging with Technetium-99m macroaggregated albumin can predict response to Yttrium-90 selective internal radiation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIR-Spheres Y-90 microspheres (yttrium-90 microspheres)
  • Technetium-99m macroaggregated albumin (Technetium-99m macroaggregated albumin)

Snippet

Sponsor: University of Magdeburg | Conditions: Colorectal Cancer, Liver Metastases | Phase 2 | Status: COMPLETED